MedTrace Logo

Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis

NCT03254589 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2025-02-26

No results posted yet for this study

Summary

The investigators will study the effects of methotrexate on blood pressure, arterial stiffness and endothelial function in patients with rheumatoid arthritis.

Conditions

Interventions

DRUG

Methotrexate

See arm descriptions

DRUG

Sulfasalazine

See arm description

DRUG

Other DMARDs

See arm

Sponsors & Collaborators

  • University of South Australia

    collaborator OTHER

  • medac GmbH

    collaborator INDUSTRY

  • Flinders University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03254589 on ClinicalTrials.gov